Why COVID sufferers in the US can’t get ensitrelvir, the antiviral drug better than Paxlovid

Why COVID sufferers in the US can’t get ensitrelvir, the antiviral drug better than Paxlovid

For people suffering through a bout of COVID-19, the antiviral Paxlovid has been a godsend. The medication emerged as the go-to antiviral treatment during the pandemic emergency after the Food and Drug Administration granted it emergency use authorization in December 2021. Now, there’s a new antiviral that’s superior to Paxlovid — but Americans can’t get … Read more